Shadi Aouad, DPM
Podiatry · Binghamton, NYNPI 1952899437
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $6,390 of the $9,578 with a category attached, or 66.7%. Treace Medical Concepts, Inc. accounts for 86.6% of it on its own, with 9 other manufacturers making up the rest. 2025 is the largest year on record at $8,200, more than ten times the $126 reported in 2023. Among podiatry clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 100 payments — averaging $95.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Treace Medical Concepts, Inc.$8K
- Arthrex$978
- Stryker$118
- Ossio Inc$50
- Solventum Corporation$42
- Bioventus LLC$22
- plus $72 from 4 others
What the payments were for
- Consulting fees$6,39067%
- Travel & lodging$1,20313%
- Food & beverage$1,98521%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Treace Medical Concepts, Inc. | 77 | $8,296 |
| Arthrex | 11 | $978 |
| Stryker | 5 | $118 |
| Ossio Inc | 1 | $50 |
| Solventum Corporation | 1 | $42 |
| Bioventus LLC | 1 | $22 |
| Prodigy Surgical Distribution, Inc. | 1 | $22 |
| IBSA Pharma Inc. | 1 | $21 |
| Paratek Pharmaceuticals, Inc. | 1 | $15 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LAPIPLASTY SYSTEM 1$6,763
- TMC NANOPLASTY SYSTEM$164
How this compares
$9,578 in reported general payments places this provider in the 95th percentile of 225 podiatry providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ciclopirox | 120 | $3,728 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 95 | $1,997 |
| Clotrimazole | 67 | $1,733 |
| Ammonium Lactate | 41 | $1,053 |
| Allopurinol | 19 | $455 |
| Methylprednisolone | 59 | $401 |
| Diclofenac Sodium | 12 | $321 |
| Doxycycline Hyclate | 26 | $248 |
| Celecoxib | 19 | $228 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 23 | $169 |
Paid to pharmacies, not to this prescriber.
Other podiatry in Binghamton
- Justin MuserBinghamton$443
- Michael RomaniBinghamton$339
- David ShafferFlushing$9K
- Samantha TrepalNew Hyde Park$3K
- Howard RosasNew York$3K
- Michael HeltMiddletown$2K
- Aaron BellewFlushing$1K
- Cindel HarrisOceanside$1K
- Stephen BennettNew York$515
- Gordon JohnBrooklyn$478
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.